The Haloperidol Tablets, cataloged under National Stock Number 6505-00-876-7239, is classified within Federal Supply Class 6505 (Drugs and Biologicals) of the Medical, Dental, and Veterinary Equipment group. The manufacturer of record is Sandoz Inc.. Government technical data includes 4 specifications, cited from the U.S. Government catalog. The record lists 2 manufacturer part numbers for this item, enabling identification through both NSN and commercial part number lookups. 3 additional reference documents (drawings, advisory and superseded references) are recorded in the U.S. Government catalog. Current acquisition status: Active. Unit of issue: BT.
| Parameter | Value |
|---|---|
| NSN | 6505-00-876-7239 |
| Primary Part Number | NDC00781-1393-10 |
| Item Name | Haloperidol Tablets |
| FSC / FSG | 6505 / 65 — Drugs and Biologicals |
| Manufacturer | Sandoz Inc. |
| Status | ACTIVE |
| Primary Container Content Quantity | 1000.000 TABLETS |
| Medical Designation and Grade | UNITED STATES PHARMACOPEIA |
| Primary Container Type | BOTTLE |
| Active Medicament Medicinal Strength | 2.000 MILLIGRAMS HALOPERIDOL ACTIVE INGREDIENT |
| Acquisition Status | ACTIVE |
| DEMIL Code | DEMIL A — No Demilitarization Required |
| Hazard | Possible hazard — SDS may be required (DLA HMIC P) |
| Criticality Code | X |
| Unit of Issue | BT |
| Part Number | Manufacturer |
|---|---|
| NDC00781-1393-10 PRIMARY | Sandoz Inc. (USA) |
| NDC00378-0214-10 | Mylan Pharmaceuticals Inc (USA) |
| Reference | Meaning |
|---|---|
| NDC00054-4344-31 | 5/9 Secondary reference Boehringer Ingelheim Roxane, Inc. Div Sub of Boehringer Ingelheim Corp |
| NDC00781-1393-10 | 5/9 Secondary reference Cardinal Health 100, Inc. |
| NDC00781-1393-10 | 5/9 Secondary reference Cardinal Health 100, Inc Dba Bindley Western Tennessee Div |
NSN 6505-00-876-7239 is a Haloperidol Tablets, manufactured by Sandoz Inc., classified under FSC 6505, Drugs and Biologicals. Status: active.
NSN 6505-00-876-7239 has 2 manufacturer part numbers on file: NDC00781-1393-10 (Sandoz Inc.), NDC00378-0214-10 (Mylan Pharmaceuticals Inc).
Key specifications for NDC00781-1393-10: Primary Container Content Quantity: 1000.000 TABLETS; Medical Designation and Grade: UNITED STATES PHARMACOPEIA; Primary Container Type: BOTTLE; Part Name Assigned by Controlling Agency: HALOPERIDOL TABLETS USP 2 MG 1000S BT. 4 specifications are documented in the U.S. Government catalog.
Possible hazard — SDS may be required (DLA HMIC P). Hazard information on this page is shown exactly as it appears in the DLA record.
U.S. Government catalog: edition PUBLOGDVD v12.0.0 (OCT 2026), edition date 2026-10-01, retrieved 2026-10-16.
U.S. Government catalog: edition PUBLOGDVD v12.0.0 (OCT 2026), edition date 2026-10-01, retrieved 2026-10-18.